Connect
MJA
MJA

Newborn bloodspot screening: setting the Australian national policy agenda

Susannah J Maxwell and Peter O’Leary
Med J Aust 2014; 200 (3): 142-143. || doi: 10.5694/mja13.10974

Australia lags behind other countries in developing a national policy framework for newborn screening

Since the late 1960s, newborn bloodspot screening (NBS) programs have successfully integrated public health and clinical medicine to identify and treat rare disease early, preventing disability and death. The management of these programs is increasingly being challenged by opportunities offered by rapidly evolving technologies, and by different perspectives on the role of screening. For NBS programs to respond effectively and consistently, a national mechanism is required to define and monitor standards and guide the introduction of new tests and technologies. This mechanism exists (or is in development) in many countries, but not in Australia.

  • Susannah J Maxwell1
  • Peter O’Leary2

  • Centre for Population Health Research, Curtin University, Perth, WA.


Competing interests:

No relevant disclosures.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.